|
FAM54B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.69120289889224E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.1467999840944E-09 |
| Normal-vs-Stage2 |
1.80683999999598E-05 |
| Normal-vs-Stage3 |
1.61829999956176E-07 |
| Normal-vs-Stage4 |
1.16760000001825E-07 |
| Stage1-vs-Stage2 |
1.532250E-01 |
| Stage1-vs-Stage3 |
9.221800E-04 |
| Stage1-vs-Stage4 |
2.762000E-02 |
| Stage2-vs-Stage3 |
2.499800E-01 |
| Stage2-vs-Stage4 |
3.305800E-01 |
| Stage3-vs-Stage4 |
9.457400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.7395997409817E-10 |
| Normal-vs-AfricanAmerican |
4.43880487921433E-11 |
| Normal-vs-Asian |
4.424500E-02 |
| Caucasian-vs-AfricanAmerican |
6.655700E-02 |
| Caucasian-vs-Asian |
3.560200E-01 |
| AfricanAmerican-vs-Asian |
7.768800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.53669990463368E-10 |
| Normal-vs-Female |
4.7901682620477E-12 |
| Male-vs-Female |
3.083900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.06679998168602E-09 |
| Normal-vs-Extreme_Weight |
9.04470000007151E-07 |
| Normal-vs-Obese |
2.14629980455072E-10 |
| Normal-vs-Extreme_Obese |
8.351700E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.453800E-02 |
| Normal_Weight-vs-Obese |
8.904200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.630400E-02 |
| Extreme_Weight-vs-Obese |
5.364300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.680800E-01 |
| Obese-vs-Extreme_Obese |
1.039370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.440900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.25090049429843E-10 |
| Normal-vs-Age(61-80Yrs) |
1.86430004767146E-09 |
| Normal-vs-Age(81-100Yrs) |
1.51600000330987E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.322200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.003000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.391400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.839800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.765900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.272300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.73910000003763E-06 |
| Normal-VS-Type2 PRCC |
1.4432899320127E-15 |
| Normal-VS-KIRP CIMP |
1.63569158218024E-12 |
| Normal-VS-Unclassified PRCC |
5.24890000019873E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.22289955939436E-11 |
| Type1 PRCC-VS-KIRP CIMP |
1.84089998800374E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
2.075700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.10239999999251E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
6.918200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.78299999606691E-08 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.5723000002541E-08 |
| Normal-vs-N1 |
<1E-12 |
| Normal-vs-N2 |
2.00689999996229E-06 |
| N0-vs-N1 |
5.42429999805805E-08 |
| N0-vs-N2 |
1.031410E-01 |
| N1-vs-N2 |
5.373400E-01 |
|
|
